
Subsidiary7 Sept 2026, 05:20 pm
Mankind Pharma Subsidiary BSVL Approves Voluntary Liquidation
AI Summary
Mankind Pharma Ltd announced that its wholly-owned subsidiary, Bharat Serums and Vaccines Limited (BSVL), has received approval from its members for voluntary liquidation. This decision was made during an Extraordinary General Meeting held on September 7, 2026. The liquidation is subject to the approval of BSVL's creditors as per the Insolvency and Bankruptcy Code, 2016. This follows earlier preparatory activities for the liquidation process, as communicated on August 26, 2026. The company has provided detailed disclosures as required by SEBI regulations.
Key Highlights
- Mankind Pharma's subsidiary, BSVL, has approved voluntary liquidation.
- Approval obtained from BSVL members in EGM on September 7, 2026.
- Liquidation is subject to creditor approval under IBC, 2016.
- Continues from earlier communication on liquidation initiation.
Price Impact
More from MANKIND